Creating centralized management of global supply chain for fast, confident decision-making
OTTAWA, ON, August 4, 2020 /CNW/ - Kinaxis® Inc. (TSX: KXS), the authority in driving agility for fast, confident decision-making in an unpredictable world, today announced that the medical systems division of FUJIFILM Corporation has selected Kinaxis RapidResponse® to gain supply chain visibility across its global supply chain. Fujifilm has leveraged its advanced imaging and information technology to become a global presence for innovation in other industries including healthcare.
Fujifilm's medical systems division, which includes, amongst other products, equipment related to X-ray diagnostic imaging, endoscopy, and In Vitro Diagnostics, will leverage the Kinaxis RapidResponse platform combined with the unique end-to-end concurrent planning technique to drive further growth and enhance the company's competitiveness. Fujifilm will use a suite of applications for supply and demand planning, integrated business planning/S&OP and inventory management to connect its global sales and manufacturing facilities and provide company-wide visibility and what-next scenario planning for enhanced supply chain efficiency, resiliency and agility.
"As growth in the medical industry is expected to continue, and as our product lineup expands, the number of items we are handling is increasing while the complexity of commercial distribution is accelerating," said Teiichi Goto, Executive Vice President, General Manager of Medical Systems Business Division, FUJIFILM Corporation. "To better respond to customer needs and make supply chain decisions quickly, it is necessary for us to understand the various market conditions as well as our domestic and overseas sales operations. By introducing Kinaxis RapidResponse, we can integrate our data from demand, supply, and inventory status into a single system with the goal to expedite decision making for optimal supply chain planning."
"We are very pleased to partner with Fujifilm to help advance its mission to contribute to the societal development and improvement of health through advanced and unique technologies," said John Sicard, CEO Kinaxis. "In an unpredictable world, our real-time digital integrated planning and analytics capabilities will provide Fujifilm greater visibility across its supply chain, giving them one version of the truth and making them more efficient and agile in their decision making."
About Kinaxis Inc.
Everyday volatility and uncertainty demand quick action. Kinaxis® delivers the agility to make fast, confident decisions across integrated business planning and the digital supply chain. People can plan better, live better and change the world. Trusted by innovative brands, we combine human intelligence with AI and concurrent planning to help companies plan for any future, monitor risks and opportunities and respond at the pace of change. Powered by an extensible, cloud-based platform, Kinaxis delivers industry-proven applications so everyone can know sooner, act faster and remove waste. For more Kinaxis news, visit Kinaxis.com or follow us on LinkedIn or Twitter.
Certain statements in this release constitute forward-looking statements within the meaning of applicable securities laws. Forward-looking statements include statements as to Kinaxis' growth opportunities and the potential benefits of, and demand for, Kinaxis' products and services. These statements are subject to certain assumptions, risks and uncertainties, including our view of the relative position of Kinaxis' products and services compared to competitive offerings in the industry. Readers are cautioned not to place undue reliance on such statements. Kinaxis' actual results, performance, achievements and developments may differ materially from the results, performance, achievements or developments expressed or implied by such statements. Risk factors that may cause the actual results, performance, achievements or developments of Kinaxis to differ materially from the results, performance, achievements or developments expressed or implied by such statements can be found in the public documents filed by Kinaxis with Canadian securities regulatory authorities. Kinaxis assumes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by law.
SOURCE Kinaxis Inc.